⌘K

Login Start Free

Home/Filings/4/0001214659-24-005208

4//SEC Filing

Hamm John M. 4

Accession 0001214659-24-005208

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 8:22 PM ET

Size

6.7 KB

Accession

0001214659-24-005208

Insider Transaction Report

Form 4

Period: 2024-03-23

CUMBERLAND PHARMACEUTICALS INCCPIX

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2024-03-23$1.81/sh−445$805→ 26,003 total
Award
Options (right to buy)
2024-03-25$1.71/sh+5,500$9,405→ 12,500 total
Exercise: $1.71From: 2028-03-25Exp: 2034-03-25→ Common Stock (5,500 underlying)

Documents

1 file

4
marketforms-65389.xmlPrimary
PRIMARY DOCUMENT

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001870439

Filing Metadata

Form type: 4
Filed: Mar 25, 8:00 PM ET
Accepted: Mar 26, 8:22 PM ET
Size: 6.7 KB

View on SEC.gov